Literature DB >> 12697265

Role of inherited defects decreasing Fas function in autoimmunity.

Umberto Dianzani1, Annalisa Chiocchetti, Ugo Ramenghi.   

Abstract

Fas is a death receptor belonging to the TNFR superfamily and induces cell apoptosis by both activating a caspase cascade and altering mitochondria. In the immune system, Fas is involved in the switching-off of the immune responses and cell mediated cytotoxicity. In humans, genetic defects decreasing Fas function cause the Autoimmune Lymphoproliferative Syndrome (ALPS) where autoimmunities are associated with accumulation of polyclonal lymphocytes in the secondary lymphoid tissues and expansion of T cells lacking both CD4 and CD8 (DN cells). Expansion of DN cells is absent in an ALPS variant, named Dianzani's Autoimmune Lymphoproliferative Disease (DALD). The observation that DALD patients' families display increased frequency of autoimmune diseases different from ALPS suggests that defects of Fas function may also play a role in development of "common" autoimmune diseases. This possibility is supported by detection of defective Fas function in substantial proportions of patients with the multiple autoimmune syndrome or aggressive forms of type 1 diabetes or multiple sclerosis. This article reviews data suggesting that development of autoimmune/lymphoproliferative patterns may involve several alterations hitting the Fas system, but might also involve alterations in other systems contributing to the switching-off or proliferation of lymphocytes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12697265     DOI: 10.1016/s0024-3205(03)00196-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  13 in total

1.  FAST is a survival protein that senses mitochondrial stress and modulates TIA-1-regulated changes in protein expression.

Authors:  Wei Li; Maria Simarro; Nancy Kedersha; Paul Anderson
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

2.  Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis.

Authors:  Hava Ben-David; Michael Sela; Edna Mozes
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-26       Impact factor: 11.205

3.  Diet as a strategy for type 1 diabetes prevention.

Authors:  Flavia Prodam; Annalisa Chiocchetti; Umberto Dianzani
Journal:  Cell Mol Immunol       Date:  2017-07-10       Impact factor: 11.530

4.  A mutation in caspase-9 decreases the expression of BAFFR and ICOS in patients with immunodeficiency and lymphoproliferation.

Authors:  N Clemente; E Boggio; C L Gigliotti; E Orilieri; G Cappellano; E Toth; P A Valletti; C Santoro; I Quinti; C Pignata; L D Notarangelo; C Dianzani; I Dianzani; U Ramenghi; U Dianzani; A Chiocchetti
Journal:  Genes Immun       Date:  2015-01-08       Impact factor: 2.676

5.  Variations of the perforin gene in patients with chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  S Buttini; G Cappellano; P Ripellino; C Briani; D Cocito; M Osio; R Cantello; U Dianzani; C Comi
Journal:  Genes Immun       Date:  2014-10-30       Impact factor: 2.676

6.  Immunity and inflammation in neurodegenerative diseases.

Authors:  Giuseppe Cappellano; Miryam Carecchio; Thomas Fleetwood; Luca Magistrelli; Roberto Cantello; Umberto Dianzani; Cristoforo Comi
Journal:  Am J Neurodegener Dis       Date:  2013-06-21

Review 7.  The "fuzzy logic" of the death-inducing signaling complex in lymphocytes.

Authors:  Craig M Walsh; Keith A Luhrs; Adrian F Arechiga
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.542

8.  Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome.

Authors:  Maurizio Aricò; Elena Boggio; Valentina Cetica; Matteo Melensi; Elisabetta Orilieri; Nausicaa Clemente; Giuseppe Cappellano; Sara Buttini; Maria Felicia Soluri; Cristoforo Comi; Carlo Dufour; Daniela Pende; Irma Dianzani; Steven R Ellis; Sara Pagliano; Stefania Marcenaro; Ugo Ramenghi; Annalisa Chiocchetti; Umberto Dianzani
Journal:  PLoS One       Date:  2013-07-01       Impact factor: 3.240

Review 9.  The role of antioxidant supplement in immune system, neoplastic, and neurodegenerative disorders: a point of view for an assessment of the risk/benefit profile.

Authors:  Daria Brambilla; Cesare Mancuso; Mariagrazia Rita Scuderi; Paolo Bosco; Giuseppina Cantarella; Laurence Lempereur; Giulia Di Benedetto; Salvatore Pezzino; Renato Bernardini
Journal:  Nutr J       Date:  2008-09-30       Impact factor: 3.271

10.  Co-inherited mutations of Fas and caspase-10 in development of the autoimmune lymphoproliferative syndrome.

Authors:  Elisa Cerutti; Maria F Campagnoli; Massimo Ferretti; Emanuela Garelli; Nicoletta Crescenzio; Angelo Rosolen; Annalisa Chiocchetti; Michael J Lenardo; Ugo Ramenghi; Umberto Dianzani
Journal:  BMC Immunol       Date:  2007-11-13       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.